arrow
A

Amit M. Oza

princess margaret cancer centre
H指数:103
被引数:5.7万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Multidisciplinary ambulatory management of malignant bowel obstruction (MAMBO) program in patients with advanced gynecological cancers: A prospective study

妇科晚期癌症患者多学科门诊管理模式(MAMBO)在恶性肠梗阻中的应用:一项前瞻性研究

2025-10-090
PRE
Elucidating divergent biology in uterine carcinosarcoma

阐明子宫癌肉瘤的异质性生物学

2025-08-230
PREAI
Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial

Rucaparib用于铂敏感、复发性卵巢癌的维持治疗:III期、随机、安慰剂对照ARIEL3试验的最终结果

2025-06-170
OA
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
ENGOT-OV16/NOVA trial of niraparib in recurrent ovarian cancer: Survival and long-term safety

ENGOT-OV16/NOVA试验中 niraparib 治疗复发卵巢癌的生存率与长期安全性

2025-04-010
PRE
Overall survival with maintenance olaparib in platinum-sensitive relapsed ovarian cancer by somatic or germline BRCA and homologous recombination repair mutation status

含体细胞或胚系BRCA和同源重组修复突变状态的铂敏感复发卵巢癌患者接受奥拉帕利维持治疗后的总生存期

2025-03-170
OA
BRCA1 secondary splice-site mutations drive exon-skipping and PARP inhibitor resistance
2024-08-050
OAAI
Maveropepimut-S, a DPX-based immune-educating therapy, combined with Pembrolizumab and Cyclophosphamide in recurrent ovarian cancer, results from the Phase 1/2 PESCO Trial
2024-03-040
PRE